Suppr超能文献

地夫可特:与其他皮质类固醇相比的治疗指数、相对效价及等效剂量

Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids.

作者信息

Parente Luca

机构信息

Department of Pharmacy, University of Salerno, Fisciano, Salerno, Italy.

出版信息

BMC Pharmacol Toxicol. 2017 Jan 5;18(1):1. doi: 10.1186/s40360-016-0111-8.

Abstract

BACKGROUND

Deflazacort is a synthetic corticosteroid characterized by a favourable pharmacokinetic profile, peculiar pharmacodynamic properties and a good safety profile. However, to the best of our knowledge, no dose-conversion table based on direct comparison of relative potencies between deflazacort and other main corticosteroids is currently available in scientific literature.

MAIN BODY

This paper, while reporting a brief review of deflazacort pharmacological properties, its efficacy and tolerability in different clinical areas, has been designed with the specific aim of providing a new dose-conversion table of corticosteroids, including for the first time also deflazacort.

SHORT CONCLUSION

We suggest that this new conversion table could be a useful tool for physicians who need to select the appropriate dose of deflazacort in their clinical practice.

摘要

背景

地夫可特是一种合成皮质类固醇,具有良好的药代动力学特征、独特的药效学特性和良好的安全性。然而,据我们所知,目前科学文献中尚无基于地夫可特与其他主要皮质类固醇相对效价直接比较的剂量换算表。

正文

本文在简要回顾地夫可特的药理特性、其在不同临床领域的疗效和耐受性的同时,旨在提供一种新的皮质类固醇剂量换算表,首次纳入了地夫可特。

简短结论

我们认为,这一新的换算表对于需要在临床实践中选择合适剂量地夫可特的医生而言可能是一个有用的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcfb/5216559/5e161e359e8f/40360_2016_111_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验